Oral Transmucosal Drugs Market

Oral Transmucosal Drugs
Oral Transmucosal Drugs Market contains market size and forecasts of Oral Transmucosal Drugs in global, including the following market information:
Global Oral Transmucosal Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Oral Transmucosal Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Oral Transmucosal Drugs companies in 2021 (%)
The global Oral Transmucosal Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Tablets Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Oral Transmucosal Drugs include LTS Lohmann Therapie-Systeme AG, Soligenix, ZIM Laboratories Limited, Access Pharmaceutical Inc., C.L Pharm, Cure Pharmaceutical, Aquestive Therapeutics, Inc., NAL Pharma and IntelGenx Corp., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Oral Transmucosal Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oral Transmucosal Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Oral Transmucosal Drugs Market Segment Percentages, by Type, 2021 (%)
Tablets
Films
Liquid Spray
Gels
Others
Global Oral Transmucosal Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Oral Transmucosal Drugs Market Segment Percentages, by Application, 2021 (%)
Cardiovascular Disorders
Acute Pain Managements
Diabetes
Others
Global Oral Transmucosal Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Oral Transmucosal Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Oral Transmucosal Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Oral Transmucosal Drugs revenues share in global market, 2021 (%)
Key companies Oral Transmucosal Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Oral Transmucosal Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
LTS Lohmann Therapie-Systeme AG
Soligenix
ZIM Laboratories Limited
Access Pharmaceutical Inc.
C.L Pharm
Cure Pharmaceutical
Aquestive Therapeutics, Inc.
NAL Pharma
IntelGenx Corp.
Eisai Co., Ltd.
Otsuka Pharmaceutical Co., Ltd.
Teva Pharmaceutical Industries Ltd.
GlaxoSmithKline plc
Viatris
Bristol-Myers Squibb Company